Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Research & Development: 2019-2024

Historic Research & Development for Caribou Biosciences (CRBU) over the last 6 years, with Dec 2024 value amounting to $130.2 million.

  • Caribou Biosciences' Research & Development fell 26.36% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $116.1 million, marking a year-over-year decrease of 11.36%. This contributed to the annual value of $130.2 million for FY2024, which is 16.13% up from last year.
  • Latest data reveals that Caribou Biosciences reported Research & Development of $130.2 million as of FY2024, which was up 16.13% from $112.1 million recorded in FY2023.
  • Caribou Biosciences' 5-year Research & Development high stood at $130.2 million for FY2024, and its period low was $34.4 million during FY2020.
  • Its 3-year average for Research & Development is $108.2 million, with a median of $112.1 million in 2023.
  • Data for Caribou Biosciences' Research & Development shows a peak YoY spiked of 57.36% (in 2022) over the last 5 years.
  • Caribou Biosciences' Research & Development (Yearly) stood at $34.4 million in 2020, then soared by 51.79% to $52.3 million in 2021, then soared by 57.36% to $82.2 million in 2022, then soared by 36.29% to $112.1 million in 2023, then climbed by 16.13% to $130.2 million in 2024.